Saving changes...

Done

Error

Current Trends in Multiple Sclerosis: Actionable Insights for Pharmacists

Current Trends in Multiple Sclerosis: Actionable Insights for Pharmacists

Current Trends in Multiple Sclerosis: Actionable Insights for Pharmacists

Jacquelyn Bainbridge, PharmD, FCCP
Jacquelyn Bainbridge, PharmD, FCCP
on behalf of Postgraduate Healthcare Education, LLC

FREE
FREE
FREE

FREE
FREE
FREE

null FREE
FREE
FREE
null FREE
FREE
FREE
Normal Price: FREE FREE

Review:

Launch date: 13 Mar 2017
Expiry Date:

Last updated: 15 Mar 2017

Reference: 172110

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

One of the most challenging aspects of effectively managing patients with multiple sclerosis (MS) is personalizing therapy for those who differ in clinical presentations, disease states, therapy response, treatment-related side-effects, and existing comorbidities. While MS is currently incurable, effective and early treatment can reduce functional and neurological symptoms and significantly improve quality of life. The role of pharmacists in all capacities in the management of patients with MS has expanded to incorporate medication management reconciliation, and consulting. Currently available therapies target immune activity, which is most active early in the disease course; thus, initiation of treatment early on is likely to result in greater efficacy and improved outcomes. Despite this, starting treatment immediately after MS is diagnosed is not currently the standard of care. This archived symposium explores the current landscape of emerging MS therapies, their efficacy, adverse event management, and pharmacoeconomic implications, as well as the role of pharmacists in patient treatment and management. Management strategies for drug-drug interactions and patient comorbidities are developed as well as strategies to identify and address causes of nonadherence.

Objectives

Objectives
At the conclusion of this activity, the participant should be able to:

-DISCUSS the rationale for MS treatment initiation, switching, and product discontinuation.
-DEVELOP management strategies for monitoring disease-modifying therapies, drug-drug interactions, and patient comorbidities as an integral and routine part of MS patient care.
-IMPLEMENT strategies to identify and address underlying causes of nonadherence and improve treatment compliance.
-ASSESS pharmacoeconomic implications and specialty pharmacy management of MS therapies.
Jacquelyn Bainbridge, PharmD, FCCP

Author Information Play Video Bio

Jacquelyn Bainbridge, PharmD, FCCP
on behalf of Postgraduate Healthcare Education, LLC

Jacquelyn Bainbridge, PharmD, FCCP Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences Department of Clinical Pharmacy and Department of Neurology University of Colorado Anschutz Medical Campus Aurora, Colorado

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.50 Hours -
    Exam Pass Rate: 75
    -
    Reference: 0064-0000-16-205-H01-P

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error